FDB (First Databank) Achieves ISO 13485:2016 Certification - Quality Management System for Medical Devices

First DatabankFDB (First Databank) announced that it has achieved ISO 13485:2016, the Quality Management System (QMS) for medical devices. This is a significant step for FDB, the UK's leading supplier of prescribing decision support solutions and it paves the way for the company's journey towards up-classification of its solutions.

FDB's solutions are integrated into healthcare systems across a wide range of settings and enable evidence-based prescribing by providing essential checks to support clinicians. ISO 13485:2016 is a widely recognised and globally defined QMS, specific to medical devices, which is audited independently on a regular basis. ISO is the International Organization for Standardization, which develops and publishes international standards.

FDB already operated a QMS significantly above ISO 9001 but was keen to enhance policies and procedures to better serve their customers, clinicians and patients. The Compliance team at FDB worked intensively over 18 months with SGS United Kingdom Ltd to achieve certification. The work involved further strengthening FDB's existing focus on quality by making sure enhanced quality controls existed at every stage of every process.

Sarah Dransfield, Information Governance Manager, FDB says: "As FDB's medical data and solutions are used in the care and treatment of patients, it is vital that we do everything to ensure that our systems, solutions and data are both as safe as possible, and compliant with all relevant laws and regulations."

Darren Nichols, Managing Director, FDB says: "We are so proud of the whole team at FDB who have worked so hard to achieve this certification. It's a significant step to go from ISO 9001 to ISO 13485:2016, which has brought about a hugely positive culture change. In a patient safety driven business, we believe adherence to this higher standard required for medical devices, is vital and means that the necessary policies and procedures are in place to enable FDB to deliver clinical decision support products of a consistently higher quality."

FDB achieved ISO 13485:2016 in January 2023 under certificate number: GB23/00000056 with SGS United Kingdom Ltd. If you would like to learn more about FDB's solutions, please click here.

About FDB

FDB (First Databank) creates and delivers the world's most powerful drug knowledge that ignites, inspires, and illuminates critical medication decisions. We collaborate with our partners to help improve patient safety, operational efficiency, and health outcomes. Our solutions drive healthcare information systems that serve the majority of hospitals, GP practices, pharmacies and many other areas of healthcare and are used by thousands of clinicians every day.

Most Popular Now

Researchers Find Telemedicine may Help R…

Low-value care - medical tests and procedures that provide little to no benefit to patients - contributes to excess medical spending and both direct and cascading harms to patients. A...

AI may Help Clinicians Personalize Treat…

Individuals with generalized anxiety disorder (GAD), a condition characterized by daily excessive worry lasting at least six months, have a high relapse rate even after receiving treatment. Artificial intelligence (AI)...

Accelerating NHS Digital Maturity: Paper…

Digitised clinical noting at South Tees Hospitals NHS Foundation Trust is creating efficiencies for busy doctors and nurses. The trust’s CCIO Dr Andrew Adair, deputy CCIO Dr John Greenaway, and...

Mobile App Tracking Blood Pressure Helps…

The AHOMKA platform, an innovative mobile app for patient-to-provider communication that developed through a collaboration between the School of Engineering and leading medical institutions in Ghana, has yielded positive results...

Can AI Help Detect Cognitive Impairment?

Mild cognitive impairment (MCI) can be an early indicator of Alzheimer's disease or dementia, so identifying those with cognitive issues early could lead to interventions and better outcomes. But diagnosing...

AI can Open Up Beds in the ICU

At the height of the COVID-19 pandemic, hospitals frequently ran short of beds in intensive care units. But even earlier, ICUs faced challenges in keeping beds available. With an aging...

Customized Smartphone App Shows Promise …

A growing body of research indicates that older adults in assisted living facilities can delay or even prevent cognitive decline through interventions that combine multiple activities, such as improving diet...

New Study Shows Promise for Gamified mHe…

A new study published in Multiple Sclerosis and Related Disorders highlights the potential of More Stamina, a gamified mobile health (mHealth) app designed to help people with Multiple Sclerosis (MS)...

AI Model Predicting Two-Year Risk of Com…

AFib (short for atrial fibrillation), a common heart rhythm disorder in adults, can have disastrous consequences including life-threatening blood clots and stroke if left undetected or untreated. A new study...

Patients' Affinity for AI Messages …

In a Duke Health-led survey, patients who were shown messages written either by artificial intelligence (AI) or human clinicians indicated a preference for responses drafted by AI over a human...

New Research Explores How AI can Build T…

In today’s economy, many workers have transitioned from manual labor toward knowledge work, a move driven primarily by technological advances, and workers in this domain face challenges around managing non-routine...

AI Tool Helps Predict Who will Benefit f…

A study led by UCLA investigators shows that artificial intelligence (AI) could play a key role in improving treatment outcomes for men with prostate cancer by helping physicians determine who...